Thus CHOP induction has been proposed as a strategy for ameliorating cancer, and pharmacological ER stresses that induce CHOP can kill cancer cells, including hepatomas, in vitro[18], [19]. This evidence concerns the gene DDIT3 and hepatocellular carcinoma.